Published on : Mar 12, 2018
Albany, New York, March 12, 2018: Cachexia is rather a very prominent sign of various underlying disorders that the person may be undergoing, one of them is cancer. It has been well identified that cachexia is a wasting condition that may have terrible repercussions if not detected and treated early in its development. Market Research Hub (MRH) has publicized a new study titled “Cancer Cachexia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” to its vast repository, which offers a strategic analysis of the global market for cancer cachexia and the growth forecast for the period 2017 to 2025.
Major Insights from the Study
Many patients with advanced cancer undergo a wasting syndrome characterized by anorexia, loss of weight, asthenia, and a poor prognosis referred to as the cancer anorexia/cachexia syndrome. According to an estimation, currently, cachexia affects around 9 million patients, globally, which is about 1% of total patient-pool across the world. Analysts project that the opportunity in this market to proliferate at a CAGR of 4.90% between 2017 and 2025 and accomplish a value of US$2.51 bn by the end of 2025. In 2016, the global cancer cachexia market stood at US$1.63 bn.
At first, the study starts by outlining the cancer cachexia market overview. In addition, the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the market and how it could influence the market in the near future. The research also analyzes global market scenario on the basis of key regions, where the market stands to gain. The Middle East and Africa (MEA), Asia Pacific excluding Japan (APEJ), Latin America, North America, Europe, and Japan are the prime regional markets for cancer cachexia across the world. It has been reported that the increasing prevalence of cachexia, especially in developed regions, such as North America, Europe, and Japan, is the foremost factor behind the significant growth of the market for cancer cachexia, worldwide. The overall market is dominated by North America and continue to remain same till 2025.
Moving further, the research study broadly categorizes the global cancer cachexia market on the basis of Therapeutics, mechanism of action, and distribution channels. Among the therapeutics available for the treatment of cancer cachexia, the demand for progestogens is comparatively higher and is expected to remain so over the next few years due to their efficiency. According to the mechanism of action, market is segmented into appetite stimulators, weight loss stabilizers, and other modes of actions. Hospital stores, retail pharmacy stores, online pharmacy are considered as preferred distribution channels.
In the later section, to assist in proper decision-making, the report includes the profiling of top players in this market. Some of the prime players functioning across the world are Aphios Corporation, Æterna Zentaris Inc., Eli Lilly and Company, Alder BioPharmaceuticals Inc., Helsinn Group, Merck & Co., Inc., Novartis AG, Bristol-Myers Squibb Company, and XBiotech, Inc.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1361040
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org